Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor
NCT00003755
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
MKC-1
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]